Warner-Lambert
This article was originally published in The Tan Sheet
Executive Summary
Pharmaceutical and dietary supplement marketer enters into agreement with "life science company" Galileo Labs "to develop an evidence-based dietary supplement...that maintains wellness," Galileo says. The supplement may be geared toward "conditions of oxidative stress that have been linked to the development and pathogenesis of cardiovascular disease...and aging." Warner-Lambert markets the Quanterra line of dietary supplements
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning